P
The startup has developed a universal testing platform that utilizes single-molecule fluorescent microscopy combined with machine learning for the digital imaging-based identification of infectious diseases. This technology enables rapid and accurate detection of unknown respiratory virus infections, enhancing diagnostic capabilities for healthcare providers.
Updated 3 months ago
Funding
$6.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup has developed a universal testing platform that utilizes single-molecule fluorescent microscopy combined with machine learning for the digital imaging-based identification of infectious diseases. This technology enables rapid and accurate detection of unknown respiratory virus infections, enhancing diagnostic capabilities for healthcare providers.